A comparative study of Tc-99(m)-d,l-HMPAO and Tc-99(m)-d,l-CBPAO as leukocyte-labelling agents

被引:5
作者
Tsai, CS [1 ]
Kao, CH [1 ]
Yeh, SJ [1 ]
Wang, SJ [1 ]
机构
[1] TAICHUNG VET GEN HOSP,DEPT NUCL MED,TAICHUNG 40705,TAIWAN
关键词
D O I
10.1097/00006231-199601000-00013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
An attempt was made to use Tc-99(m)-d,l-cyclobutylpropylene amine oxime (Tc-99(m)-d,l-CBPAO) to label leukocytes. The radiochemical purity of Tc-99(m)-d,l-CBPAO, labelling efficiency of leukocytes, cell viability of labelled leukocytes and stability of Tc-99(m)-d,l-CBPAO-labelled leukocytes were calculated. In comparison with the commercial cell-labelling agent Tc-99(m)-d,l-hexamethylpropylene amine oxime (Tc-99(m)-d,l-HMPAO), (1) the radiochemical purity of Tc-99(m)-d,l-CBPAO was higher than that of Tc-99(m)-d,l-HMPAO immediately after and 1, 2, 4, 6, 8 and 24 h after Tc-99(m) labelling; (2) the labelling efficiency of Tc-99(m)-d,l-CBPAO-labelled leukocytes was lower than that of Tc-99(m)-d,l-HMPAO; (3) the viability of labelled white blood cells was high for both agents; and (4) the stability of Tc-99(m)-d,l-CBPAO-labeIled leukocytes was better than that of Tc-99(m)-d,l-HMPAO after 1, 2, 4, 6, 8 and 24 h. In conclusion, although the labelling efficiency of Tc-99(m)-d,l-CBPAO is lower, it is more stable than Tc-99(m)-d,l-HMPAO and provides greater stability of Tc-99(m)-d,l-CBPAO-labeIled leukocytes. Therefore, Tc-99(m)-d,l-CBPAO has the potential to replace Tc-99(m)-d,l-HMPAO as a commercial leukocyte-labelling agent.
引用
收藏
页码:76 / 79
页数:4
相关论文
共 16 条
  • [1] EVALUATION OF TECHNETIUM 99M CYCLOBUTYLPROPYLENE AMINE OXIME AS A POTENTIAL BRAIN PERFUSION IMAGING AGENT FOR SPET
    BACCIOTTINI, L
    LUNGHI, F
    PUPI, A
    BONINO, C
    FORMICONI, AR
    DECRISTOFARO, MTR
    PETTI, ARM
    MELDOLESI, U
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 17 (05): : 242 - 247
  • [2] COMPARISON OF TC-99M-HMPAO AND IN-111-OXINE LABELED GRANULOCYTES IN MAN - 1ST CLINICAL-RESULTS
    BECKER, W
    SCHOMANN, E
    FISCHBACH, W
    BORNER, W
    GRUNER, KR
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1988, 9 (06) : 435 - 447
  • [3] COLASLINHART N, 1984, BLOOD CELLS NUCL M 2, P117
  • [4] COLOMBO F, 1990, TECHNETIUM RHENIUM C, P469
  • [5] HUNG JC, 1989, NUCL MED BIOL, V16, P675
  • [6] A COMPARATIVE-STUDY OF 99TCM-HMPAO AND 99TCM-ECD AS A LEUKOCYTE LABELING AGENT
    KAO, CH
    HUANG, WT
    WANG, YL
    LIN, KS
    LO, JM
    WANG, SJ
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (04) : 294 - 297
  • [7] KAO CH, 1992, J NUCL MED TECHNOL, V20, P224
  • [8] LANTTO EH, 1991, J NUCL MED, V32, P2029
  • [9] MCAFEE JG, 1976, J NUCL MED, V17, P480
  • [10] MCAFEE JG, 1976, J NUCL MED, V17, P488